United States of America
After obtaining her M.D. degree in China, Dr. Chen decided to switch her career path from clinical medicine to basic research with a singular goal: to gain a better understanding of cancer biology so we can one day provide effective treatments and perhaps even cures. She came to the United States to pursue her graduate research career in Roswell Park Cancer Institute. After obtaining her Ph.D, she joined Dr. Joan Massagué’s group in Memorial Sloan-Kettering Cancer Center as a postdoctoral fellow. In October 2015, Dr. Chen joined the Tumor Microenvironment and Metastasis Program at the Wistar Institute.
3) Fisher DT, Chen Q, Skitzki JJ, Muhitch JB, Zhou L, Appenheimer MM, Vardam TD, Weis EL, Passanese J, Wang WC, Gollnick SO. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. The Journal of clinical investigation. 2011 Oct 3;121(10):3846.
2) Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E, Massagué J. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 2014 Feb 27;156(5):1002-16.
1) Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob L, Patwa R, Shah H, Xu K, Cross JR. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 2016 May 26;533(7604):493.